Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Realworld timelines vary depending on the specific peptide, dose, adherence, and how well nutrition, movement, and sleep are addressed alongside the medication
Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis
Many patients start with weekly sessions for 4-6 weeks, then transition to monthly maintenance
The list of species and NCBI accession numbers, as well as the corresponding peptide sequences, are provided in Supplementary Tables 15 and 16
Thymosin 4 and its derivatives (explicitly including TB-500) are listed under the S2 growth-factors category, and BPC-157 was added to the Prohibited List in 2022 under S0 (non-approved substances)
US$ 24.65
US$ 29.29
US$ 28.54
US$ 25.15
US$ 25.50
US$ 26.61
